MedTrace Logo

Effectiveness of Intraoperative Cell Salvage in Aseptic Revision Total Hip Arthroplasty.

NCT05237830 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2022-02-14

No results posted yet for this study

Summary

Intraoperative cell salvage is an important measure of patient blood management but its effectiveness in patients undergoing revision total hip arthroplasty remains unclear. Over the last decade, we have used intraoperative cell salvage systematically in this group of patients. However, since the use of cell salvage has a cost and requires additional resources, we decided to retrospectively investigate its usefulness in this particular indication.

Conditions

  • Revision of Total Hip Arthroplasty

Interventions

PROCEDURE

Use of Cell Salvage in revision of total hip arthroplasty

The effective use of the cell saver was defined as the ability to re-transfuse at least 125 mL of re-suspended red blood cells with a hematocrit of 60 %.

Sponsors & Collaborators

  • University of Liege

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-01
Primary Completion
2021-12-31
Completion
2022-01-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05237830 on ClinicalTrials.gov